Clinical Trial Update: CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

View source ↗

Summary

This document reports the completion of CEPHEUS II, a centralized Pan-Russian survey evaluating undertreatment of dyslipidemia, including hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidaemia | Status: COMPLETED